Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 26,513 | 41,750 | 30,370 | 39,597 | 32,265 |
| Operating Income | -26,513 | -41,750 | -30,370 | -39,597 | -32,265 |
| Interest Expense | 1,068 | 1,046 | 1,023 | 1,037 | 1,027 |
| Other Income | 1,130 | 1,846 | 2,597 | 3,480 | 3,527 |
| Pre-tax Income | -26,451 | -40,950 | -28,796 | -37,154 | -29,765 |
| Net Income Continuous | -26,451 | -40,950 | -28,796 | -37,154 | -29,765 |
| Net Income | $-26,451 | $-40,950 | $-28,796 | $-37,154 | $-29,765 |
| EPS Basic Total Ops | -0.44 | -0.68 | -0.48 | -0.62 | -0.50 |
| EPS Basic Continuous Ops | -0.44 | -0.68 | -0.48 | -0.62 | -0.50 |
| EPS Diluted Total Ops | -0.44 | -0.68 | -0.48 | -0.62 | -0.50 |
| EPS Diluted Continuous Ops | -0.44 | -0.68 | -0.48 | -0.62 | -0.50 |
| EPS Diluted Before Non-Recurring Items | -0.44 | -0.68 | -0.48 | -0.62 | -0.50 |
| EBITDA(a) | $-26,741 | $-41,759 | $-30,913 | $-39,969 | $-33,597 |